(OWL) Blue Owl Capital - Overview
Stock: Direct Lending, GP Stakes, Net Lease, Real Estate Credit, Credit
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.53% |
| Yield on Cost 5y | 9.67% |
| Yield CAGR 5y | 60.14% |
| Payout Consistency | 100.0% |
| Payout Ratio | 142.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 60.6% |
| Relative Tail Risk | -1.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.21 |
| Alpha | -71.69 |
| Character TTM | |
|---|---|
| Beta | 1.738 |
| Beta Downside | 2.021 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.41% |
| CAGR/Max DD | 0.07 |
Description: OWL Blue Owl Capital December 17, 2025
Blue Owl Capital Inc. (NYSE: OWL) is a U.S.-based alternative asset manager that leverages a permanent-capital structure to deliver a suite of financing solutions to middle-market companies, large alternative managers, and owners or tenants of corporate real estate. Its product set spans direct-lending (including diversified, technology-focused, first-lien and opportunistic loans), a range of credit strategies (alternative, investment-grade, liquid), GP strategic capital (minority stakes, GP debt, and sports-team investments), and real-estate assets centered on triple-net leases and related debt financing.
As of the most recent filing, Blue Owl reported approximately $70 billion in assets under management, with private credit accounting for roughly 45 % of that total-a sector that has grown at a 12 % CAGR over the past five years, driven by corporations’ appetite for non-bank financing amid tighter bank lending standards. The firm’s net investment income margin has hovered near 55 % of revenue, reflecting the higher yields typical of first-lien and opportunistic credit exposures. Additionally, the company’s exposure to triple-net lease properties benefits from a low-vacancy, inflation-linked rent environment, a macro trend that supports stable cash flows in a rising-rate backdrop.
For a deeper quantitative view, consult ValueRay’s dashboard on OWL’s credit-adjusted returns to see how these drivers translate into risk-adjusted performance.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 51.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.85 > 1.0 |
| NWC/Revenue: 8.23% < 20% (prev 2.56%; Δ 5.67% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.20b > Net Income 51.9m |
| Net Debt (3.64b) to EBITDA (780.4m): 4.66 < 3 |
| Current Ratio: 1.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (673.9m) vs 12m ago 22.78% < -2% |
| Gross Margin: 53.09% > 18% (prev 0.55%; Δ 5254 % > 0.5%) |
| Asset Turnover: 23.65% > 50% (prev 20.07%; Δ 3.58% > 0%) |
| Interest Coverage Ratio: 2.64 > 6 (EBITDA TTM 780.4m / Interest Expense TTM 155.5m) |
Altman Z'' -0.29
| A: 0.02 (Total Current Assets 863.2m - Total Current Liabilities 637.3m) / Total Assets 12.47b |
| B: -0.12 (Retained Earnings -1.51b / Total Assets 12.47b) |
| C: 0.04 (EBIT TTM 409.7m / Avg Total Assets 11.61b) |
| D: -0.24 (Book Value of Equity -1.51b / Total Liabilities 6.29b) |
| Altman-Z'' Score: -0.29 = B |
Beneish M -2.94
| DSRI: 0.96 (Receivables 680.6m/556.3m, Revenue 2.75b/2.16b) |
| GMI: 1.03 (GM 53.09% / 54.88%) |
| AQI: 0.98 (AQ_t 0.88 / AQ_t-1 0.89) |
| SGI: 1.27 (Revenue 2.75b / 2.16b) |
| TATA: -0.09 (NI 51.9m - CFO 1.20b) / TA 12.47b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of OWL shares?
Over the past week, the price has changed by -8.21%, over one month by -21.95%, over three months by -15.01% and over the past year by -47.14%.
Is OWL a buy, sell or hold?
- StrongBuy: 8
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OWL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.1 | 60.7% |
| Analysts Target Price | 20.1 | 60.7% |
| ValueRay Target Price | 13.3 | 5.9% |
OWL Fundamental Data Overview February 03, 2026
P/E Forward = 13.986
P/S = 7.765
P/B = 4.051
P/EG = 0.1883
Revenue TTM = 2.75b USD
EBIT TTM = 409.7m USD
EBITDA TTM = 780.4m USD
Long Term Debt = 3.23b USD (from longTermDebt, last quarter)
Short Term Debt = 130.0m USD (from shortTermDebt, last fiscal year)
Debt = 3.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.64b USD (from netDebt column, last quarter)
Enterprise Value = 24.96b USD (21.32b + Debt 3.78b - CCE 137.3m)
Interest Coverage Ratio = 2.64 (Ebit TTM 409.7m / Interest Expense TTM 155.5m)
EV/FCF = 21.72x (Enterprise Value 24.96b / FCF TTM 1.15b)
FCF Yield = 4.60% (FCF TTM 1.15b / Enterprise Value 24.96b)
FCF Margin = 41.85% (FCF TTM 1.15b / Revenue TTM 2.75b)
Net Margin = 1.89% (Net Income TTM 51.9m / Revenue TTM 2.75b)
Gross Margin = 53.09% ((Revenue TTM 2.75b - Cost of Revenue TTM 1.29b) / Revenue TTM)
Gross Margin QoQ = 53.11% (prev 53.59%)
Tobins Q-Ratio = 2.00 (Enterprise Value 24.96b / Total Assets 12.47b)
Interest Expense / Debt = 1.12% (Interest Expense 42.4m / Debt 3.78b)
Taxrate = 14.37% (7.95m / 55.3m)
NOPAT = 350.8m (EBIT 409.7m * (1 - 14.37%))
Current Ratio = 1.35 (Total Current Assets 863.2m / Total Current Liabilities 637.3m)
Debt / Equity = 1.65 (Debt 3.78b / totalStockholderEquity, last quarter 2.30b)
Debt / EBITDA = 4.66 (Net Debt 3.64b / EBITDA 780.4m)
Debt / FCF = 3.17 (Net Debt 3.64b / FCF TTM 1.15b)
Total Stockholder Equity = 2.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.45% (Net Income 51.9m / Total Assets 12.47b)
RoE = 2.28% (Net Income TTM 51.9m / Total Stockholder Equity 2.28b)
RoCE = 7.43% (EBIT 409.7m / Capital Employed (Equity 2.28b + L.T.Debt 3.23b))
RoIC = 6.57% (NOPAT 350.8m / Invested Capital 5.34b)
WACC = 10.61% (E(21.32b)/V(25.10b) * Re(12.32%) + D(3.78b)/V(25.10b) * Rd(1.12%) * (1-Tc(0.14)))
Discount Rate = 12.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 17.48%
[DCF Debug] Terminal Value 73.26% ; FCFF base≈1.05b ; Y1≈1.29b ; Y5≈2.21b
Fair Price DCF = 31.02 (EV 24.26b - Net Debt 3.64b = Equity 20.62b / Shares 664.8m; r=10.61% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -10.03 | EPS CAGR: -42.32% | SUE: -3.34 | # QB: 0
Revenue Correlation: 98.97 | Revenue CAGR: 27.99% | SUE: 1.14 | # QB: 6
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=-0.005 | Revisions Net=-3 | Analysts=14
EPS next Year (2026-12-31): EPS=0.97 | Chg30d=-0.022 | Revisions Net=-10 | Growth EPS=+17.6% | Growth Revenue=+17.1%